Hwail Pharmaceutical Co.,Ltd. (KOSDAQ:061250)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,071.00
+1.00 (0.09%)
At close: Feb 13, 2026
Market Cap91.03B -13.5%
Revenue (ttm)107.87B -4.8%
Net Income1.92B -80.8%
EPS47.45 -80.9%
Shares Out85.00M
PE Ratio22.57
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume230,956
Average Volume375,122
Open1,070.00
Previous Close1,070.00
Day's Range1,052.00 - 1,071.00
52-Week Range1,003.00 - 1,470.00
Beta0.29
RSI47.08
Earnings Daten/a

About Hwail Pharmaceutical

Hwail Pharmaceutical Co.,Ltd. develops pharmaceutical raw materials in South Korea. It provides raw drug products, finished drug products, and functional health food raw material business. The company was founded in 1974 and is headquartered in Seongnam-si, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 1974
Employees 130
Stock Exchange KOSDAQ
Ticker Symbol 061250
Full Company Profile

Financial Performance

In 2016, Hwail Pharmaceutical's revenue was 111.52 billion, an increase of 5.08% compared to the previous year's 106.13 billion. Earnings were 6.38 billion, an increase of 17.03%.

Financial Statements